Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer

Publisher： Karger

E-ISSN： 2235-0802|5|3|187-194

ISSN： 2235-0640

Source： European Thyroid Journal, Vol.5, Iss.3, 2016-09, pp. : 187-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

2012 European Thyroid Association Guidelines for Metastatic Medullary Thyroid Cancer

By  

European Thyroid Journal, Vol. 1, Iss. 1, 2012-03 ,pp. : 5-14

Karger

Access to resources Recommend Favorite

Medullary Thyroid Cancer: Molecular Biology and Novel Molecular Therapies

By  

Neuroendocrinology, Vol. 90, Iss. 4, 2009-05 ,pp. : 323-348

Karger

Access to resources Recommend Favorite

2012 European Thyroid Association Guidelines for Genetic Testing and Its Clinical Consequences in Medullary Thyroid Cancer

By  

European Thyroid Journal, Vol. 1, Iss. 4, 2012-12 ,pp. : 216-231

Karger

Access to resources Recommend Favorite

2012 European Thyroid Association Guidelines for Metastatic Medullary Thyroid Cancer Urge Restrained Use of Novel Kinase Inhibitors

By  

European Thyroid Journal, Vol. 1, Iss. 1, 2012-03 ,pp. : 3-4

Karger

Access to resources Recommend Favorite

Development and Application of a Novel Sensitive Immunometric Assay for Calcitonin in a Large Cohort of Patients with Medullary and Differentiated Thyroid Cancer, Thyroid Nodules, and Autoimmune Thyroid Diseases

By  

European Thyroid Journal, Vol. 3, Iss. 2, 2014-06 ,pp. : 117-124

Karger

Access to resources Recommend Favorite